JEAN PETTINATO: Open Payments
NPI 1265202378 · WILKES BARRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 46 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $233 · 2025 $1,163
Food & beverage: $1,163
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $304 |
| Teva Pharmaceuticals USA, Inc. | 8 | $208 |
| Vanda Pharmaceuticals Inc. | 6 | $197 |
| E.R. Squibb & Sons, L.L.C. | 3 | $145 |
| Neurocrine BioSciences, Inc. | 8 | $141 |
| Janssen Pharmaceuticals, Inc | 4 | $85 |
| Lundbeck LLC | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
Products named: CAPLYTA, UZEDY, FANAPT, COBENFY, INGREZZA, INVEGA SUSTENNA, REXULTI, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
